These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6128876)

  • 21. Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
    Usuda S; Sano K; Maeno H
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):68-78. PubMed ID: 43118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects].
    Casais L; Colom A; Martín del Río MP; Vallejo M; Cuenca E
    Arch Farmacol Toxicol; 1979 Dec; 5(3):159-64. PubMed ID: 44673
    [No Abstract]   [Full Text] [Related]  

  • 24. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 25. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
    J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Significance of the dopamine-blocking and m-choline-blocking components in the antiapomorphine action of neuroleptics].
    Zharkovskiĭ AM; Langel IuL; Chereshka KS; Zharkovskaia TA
    Biull Eksp Biol Med; 1987 Mar; 103(3):317-9. PubMed ID: 2881585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioural actions of neuroleptics are not reduced by hypophysectomy.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    J Pharm Pharmacol; 1982 Sep; 34(9):588-90. PubMed ID: 6127386
    [No Abstract]   [Full Text] [Related]  

  • 28. 3-substituted-1,2-benzisoxazoles: novel antipsychotic agents.
    Davis L; Effland RC; Klein JT; Dunn RW; Geyer HM; Petko WW
    Drug Des Discov; 1992 Feb; 8(3):225-40. PubMed ID: 1356026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(3):327-30. PubMed ID: 8106091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 31. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in the induction of behavioral supersensitivity by prolonged treatment with atypical neuroleptics.
    Halperin R; Guerin JJ; Davis KL
    Psychopharmacology (Berl); 1989; 98(3):386-91. PubMed ID: 2568659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The substituted benzamides--a novel class of dopamine antagonists.
    Jenner P; Marsden CD
    Life Sci; 1979 Aug; 25(6):479-85. PubMed ID: 40086
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-dopaminergic activity of pyrrolidinyl-benzamide derivatives].
    Usuda S
    Yakugaku Zasshi; 1987 Sep; 107(9):711-9. PubMed ID: 3437398
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic aspects of some behavioral effects of psychotropic drugs.
    Melzacka M
    Pol J Pharmacol Pharm; 1984; 36(2-3):117-36. PubMed ID: 6147827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of the dopamine antagonist remoxipride on apomorphine induced behaviour in the rat.
    Ståhle L; Ljungberg T; Rodebjer A; Ogren SO; Ungerstedt U
    Pharmacol Toxicol; 1987 Mar; 60(3):227-32. PubMed ID: 2884654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 12-chloroscoulerine enantiomers on animal behavior to dopamine receptors.
    Chen LJ; Zhou QT; Dong ZJ; Yu LP; Jin GZ
    Zhongguo Yao Li Xue Bao; 1999 Oct; 20(10):884-8. PubMed ID: 11270985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and neuroleptic activity of benzamides. Cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide and related compounds.
    Iwanami S; Takashima M; Hirata Y; Hasegawa O; Usuda S
    J Med Chem; 1981 Oct; 24(10):1224-30. PubMed ID: 6120234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the mouse circling model to demonstrate enhanced striatal actions for oxiperomide and tiapride following denervation [proceedings].
    Costall B; Naylor RJ; Nohria V
    Br J Pharmacol; 1979 May; 66(1):121P. PubMed ID: 36952
    [No Abstract]   [Full Text] [Related]  

  • 40. Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat.
    Lipska BK; Jaskiw GE; Braun AR; Weinberger DR
    Biol Psychiatry; 1995 Aug; 38(4):255-62. PubMed ID: 8547448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.